Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, Mechanistic insight into Metastasis progression: IL-17 increases the expression of Zeb2, an epithelial to mesenchymal transition (EMT) promoter, via down regulation of its target gene, 09/February/2015, 22.31, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Significance: This study suggests that IL-17, by decreasing the expression of its target gene, it may increase the expression of Zeb2. Thereby, it may promote epithelial to mesenchymal transition (EMT) and metastasis. Thus, pharmacological formulations encompassing “IL-17 inhibitors“ may be used to inhibit the progression of tumors.
Amount: $ 300
Undisclosed information: How IL-17 increases the expression of Zeb2
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
